Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements
Pharmaceuticals · 28.11.2023 · 16 (12) · 1658
DOI: 10.3390/ph16121658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 28.11.2023. Verfasst von Sabrina Magramane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Semmelweis University, Hőgyes Str. 7, H-1092 Budapest, Hungary. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this review, an extensive analysis of dry powder inhalers (DPIs) is offered, focusing on their characteristics, formulation, stability, and manufacturing. The advantages of pulmonary delivery were investigated, as well as the significance of the particle size in drug deposition. The preparation of DPI formulations was also comprehensively explored, including physico-chemical characterization of powders, powder processing techniques, and formulation considerations. In addition to manufacturing procedures, testing methods were also discussed, providing insights into the development and evaluation of DPI formulations. This review also explores the design basics and critical attributes specific to DPIs, highlighting the significance of their optimization to achieve an effective inhalation therapy. Additionally, the morphology and stability of 3 DPI capsules (Spiriva, Braltus, and Onbrez) were investigated, offering valuable insights into the properties of these formulations. Altogether, these findings contribute to a deeper understanding of DPIs and their development, performance, and optimization of inhalation dosage forms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Semmelweis University, Hőgyes Str. 7, H-1092 Budapest, Hungary.
- Department of Electronics Technology, Budapest University of Technology and Economics, Egry J. Str. 18, H-1111 Budapest, Hungary.
- Department of Pharmacy Administration, Semmelweis University, Hőgyes Str. 7-9, H-1092 Budapest, Hungary.
ORCID-Profile: Sabrina Magramane, Nikolett Kállai-Szabó
Zitieren
APA
Magramane, S., Vlahović, K., Gordon, P., Kállai-Szabó, N., Zelkó, R., Antal, I., & Farkas, D. (2023). Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. Pharmaceuticals, 16(12), 1658. https://doi.org/10.3390/ph16121658
Vancouver
Magramane S, Vlahović K, Gordon P, Kállai-Szabó N, Zelkó R, Antal I, et al. Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. Pharmaceuticals. 2023;16(12):1658. doi:10.3390/ph16121658
BibTeX
@article{Magramane2023,
author = {Magramane, Sabrina and Vlahović, Kristina and Gordon, Péter and Kállai-Szabó, Nikolett and Zelkó, Romána and Antal, István and Farkas, Dóra},
title = {Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {12},
pages = {1658},
doi = {10.3390/ph16121658}
}
EUVIMED